GLP-1 receptor agonists — Articles & guides | Uplevel Bio

Compound

Everything we've written on GLP-1 receptor agonists — 18 articles covering the mechanism, the evidence, comparisons, and practical considerations.

18 articles

Metabolic healthGLP-1s and alcohol — the off-label effect nobody planned forYou started semaglutide for your weight, and somewhere around week six you noticed something nobody warned you about. The glass of wine you poured at the end of the workday sat on the counter. Not because you decided not to drink it. You just forgot it was there. The craving that usually showed up around 6 PM — specific, familiar, a little impatient — didn't. And then the next night, same thing. And the night after that. You mentioned it to a friend who was also on a GLP-1 and she laughed and said she'd stopped buying wine entirely because she kept letting bottles go bad.7 min read Skin and metabolic healthThe 'GLP-1 face' — what's actually happening to your skin during fast weight lossYou're down thirty pounds and people keep saying you look amazing, and you smile and thank them, and then you go home and look at the mirror at a certain angle under certain light and you don't recognize yourself. Not in the way the compliments imply. The temples look hollow. The cheeks have dropped in a way that makes the lower face look heavy and the midface look empty. There are folds running from your nose to your chin that weren't pronounced before. You look, honestly, older than you did before you lost the weight. Not sick — just like a faster version of the face you expected to have in ten years.7 min read Metabolic healthThe GLP-1 family tree — from Exenatide to RetatrutideIn 2005, a diabetes drug derived from gila monster venom got approved by the FDA and most people shrugged. Endocrinologists noticed. A handful of researchers noticed. The broader world did not. Seventeen years later, the cultural conversation around weight and metabolism would be transformed by a molecule descended from that same biological lineage — and suddenly everyone wanted to understand where it came from. The GLP-1 family tree is the answer to that question. It's a story of pharmaceutical iteration, each generation solving problems the last one left behind, each generation expanding what the biology could be asked to do.9 min read Metabolic healthThe GLP-1 muscle loss problem (and how to protect lean mass on the protocol)The scale is moving in the right direction and you feel like you should feel better about it. Some weeks you do. Other weeks you notice something harder to name — a flatness in your workouts, a loss of strength that doesn't match the number of weeks you've been training, a body that's lighter but somehow not quite right. The clothes fit differently but not in all the ways you expected. You mention it to people and they tell you that you look great. That's not exactly what you asked.8 min read Metabolic healthMicrodose vs full-dose GLP-1 — picking the right intensity for the right goalYou've done the reading. You know GLP-1 receptor agonists exist. You know they work. But the conversation around them — the before-and-afters, the celebrity speculation, the prescribing provider ads — all seems to point at one thing: the full dose, the dramatic weight loss, the transformation narrative. And that's not quite what you're looking for. Or maybe it is, and you're not sure. You're trying to figure out whether the intensity of the intervention matches the intensity of your situation, and nobody has given you a framework for that.7 min read Women's hormonal healthPCOS — the metabolic-reproductive condition and the peptide conversationYour cycles have never been regular. Or they were, and then they weren't. Your skin produces oil faster than you can manage it; there are cysts along your jawline that come back in the same places regardless of what you use. There is hair growing where you don't want it — along the chin, the sideburns, sometimes the abdomen — and hair thinning where you do. Your weight doesn't behave the way effort should predict: you eat carefully, you exercise, and the number on the scale moves reluctantly or not at all, while visceral fat distributes itself around your waist in a pattern that feels metabolic rather than dietary. When you mention any of this in a clinical context, you are sometimes told you have PCOS; sometimes you are told you might; sometimes you are told to lose weight, as though that were the first step rather than a symptom of the same underlying dysregulation that's driving everything else. The diagnosis, when it arrives, often arrives late — sometimes years after the symptoms began, sometimes only when fertility becomes the immediate concern.10 min read Compounding and compliancePeptide drug interactions — what to flag with your prescribing providerYou've been on metformin and a statin for two years. You're about to start a peptide protocol — sermorelin, maybe BPC-157, possibly a GLP-1. Your prescribing provider is aware of the peptides. Your primary care doctor is aware of the metformin and statin. Neither provider has the full picture, and you're sitting with a list of compounds and a reasonable question: do any of these interact?9 min read Compounding and compliancePeptide realistic timelines — what to actually expect, whenYou read the protocol description and something says "noticeable effects within days." You start, you track carefully, and two weeks in you're not sure if anything is happening. You're trying to figure out whether this is normal — a waiting game you need to play out — or a signal that this compound isn't working for you and you should reassess. The uncertainty is uncomfortable, and it's entirely predictable, because the timeline language most people encounter before starting is almost never honest about what biology actually requires.8 min read Compounding and complianceWhen to choose peptides vs traditional approaches — the meta-decision frameworkYou've been reading about peptides long enough that you've started wondering whether you're looking at a legitimate part of modern medicine or a sophisticated version of the supplement industry's tendency to package hope in molecular language. That skepticism is healthy. It's also incomplete. The honest answer is that peptides occupy a real but specifically bounded place in the clinical landscape, and the question isn't whether they belong there — they do — but when they're the right tool and when something else is.9 min read Anti-aging and cellular healthPeptides in aesthetic medicine — beyond the skincare aisleYou've spent real money on a serum with peptides in the name and a long list of ingredients that require a chemistry degree to evaluate. Maybe it made a difference. Maybe the skin looked slightly better for a few weeks and you're not sure whether that was the product, the new moisturizer you added at the same time, or simply the fact that winter ended. This is the experience most people have with cosmetic peptide products — a combination of genuine possibility and genuine uncertainty that the marketing does not help you sort out.10 min read Immune modulationPeptides for cardiovascular health — endothelial function, recovery, longevityThe heart attack doesn't arrive unannounced if you know what you're looking for. For years before the event, the arteries have been quietly accumulating damage — endothelial cells stressed by LDL oxidation, inflammatory cells migrating into vessel walls, smooth muscle cells proliferating, plaques forming and slowly expanding. The process is silent, invisible to ordinary sensation, progressing through decades of meals and stress and inadequate sleep until a plaque ruptures and the clot that forms in the aftermath blocks a coronary artery completely. Most people who have their first myocardial infarction had normal cholesterol by conventional standards. The disease is real and progressing long before the metrics look alarming.11 min read Metabolic healthPeptides for diabetes and blood sugar — the incretin revolution and beyondYou eat the sandwich and your energy crashes an hour later. Not dramatically — you don't lose consciousness, you don't shake. But there's a particular kind of slump, a fogginess that settles in, a craving for something sweet that doesn't quite match your hunger, and you find yourself in the afternoon with less to give than you should. Blood sugar dysregulation at its subclinical edges doesn't announce itself with crisis symptoms. It shows up as a pattern: the energy inconsistency, the difficulty losing weight despite reasonable effort, the fasting glucose trending upward at each annual physical, the waistline that keeps expanding regardless of what you do. And then one day a number crosses a threshold — fasting glucose over 100, HbA1c at 5.7 — and what was subclinical becomes a diagnosis.11 min read Metabolic healthPeptides for fat loss — what research has explored, by mechanismYou have done the things. You track what you eat. You work out. You drink water. And yet the number moves slowly if it moves at all, and the distribution of fat on your body seems indifferent to your effort in ways that feel not quite fair. The conventional answer is that you're not in a sufficient caloric deficit, and that may be technically true, but it sidesteps the part where caloric deficit is harder for some bodies than others — where hunger signals are different, where metabolic rates differ, where fat distribution is being regulated by hormonal signals you can't control with willpower.10 min read Immune modulationPeptides with chronic kidney disease — what changes when the kidneys aren't working at baselineYour creatinine has been creeping for three years. You're at stage 3b now, eGFR in the low forties, already on an ACE inhibitor and a statin, watching your potassium and phosphate at every appointment. You've read about GLP-1 agonists in the context of metabolic health and wondered if they apply to you. You've heard about peptides in various wellness contexts and wondered what, if any, of that conversation is relevant to someone whose kidneys are already compromised. Your nephrologist is focused on slowing the progression. The peptide conversation isn't one you've been able to have with her in any structured way.9 min read Immune modulationPeptides with liver disease — the metabolism question changes everythingThe ultrasound report says mild to moderate steatosis. Or the fibroscan number is creeping. Or the ALT has been elevated for two years and you've just been told it might be MASH — metabolic dysfunction-associated steatohepatitis, the new name for what used to be called NASH — and your hepatologist is talking about lifestyle modification and watching the fibrosis score. You've been reading about peptides. Some of what you're reading seems directly relevant to the liver. Some of it makes you cautious. You're not sure where the line is.9 min read Metabolic healthPost-bariatric surgery and the peptide conversationThree years out from your sleeve gastrectomy, you've kept off most of the weight. But not all of it. The scale has been creeping upward for six months — not dramatically, but persistently — and you've noticed that the food noise, which went nearly silent in the first year, has started to return. Your body composition is different from what you expected: softer than you imagined you'd be at this weight, less muscle than the number on the scale implies. You're eating right, working with your bariatric team, taking your vitamins. And yet the trajectory feels different from what surgery promised, and you're starting to ask questions your bariatric program doesn't have obvious answers to.9 min read Women's hormonal healthPreconception and peptides — what to discontinue before trying to conceiveYou've been on a peptide protocol for six months. The body composition is better, sleep is better, the metabolic markers have moved in the right direction. And now you and your partner are talking seriously about timing — the conversation is shifting from optimization to readiness, and your reproductive endocrinologist has started discussing the actual conception window. You want to do this thoughtfully. You're not sure which of what you're taking needs to stop before you start trying, and nobody in your care team has given you a clear answer.7 min read Recovery and inflammationSurgery and peptides — what to discontinue before, what to restart afterYou have a surgery scheduled. It might be elective — a knee repair, a hernia, a procedure you've been planning for months. Or it came up faster than expected and you've got two weeks. Either way, you're currently on a peptide protocol, and the standard pre-operative paperwork asks about medications and supplements, and you're staring at a checkbox wondering whether any of this applies to you, and whether the surgeon or anesthesiologist managing your procedure has any idea how to answer that question.9 min read

← All articles